GENE ONLINE|News &
Opinion
Blog

Opioid
Trials & Approvals Overdose
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Special Opioid
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
2022-11-15
M&A Opioid
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Policy Opioid
CDC Unveils Updated Set of Opioid Prescription Guidelines
2022-11-04
Regulatory Overdose
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Funding Pain Management
Allay Therapeutics Raises $60 Million to Finance its Non-Opioid Pain Management Platform
2021-09-16
Feature Cannabidiol
Spotlight: Cannabidiol (CBD) Based Medication Heralds New Promise in Neurological Therapies
2020-09-22
Trials & Approvals Pain Management
Trevena Inc. Gives Oliceridine Approval Another Shot
2020-02-11
LATEST
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
Partnership to Manufacture Antibiotic to Combat Antimicrobial Resistance
2023-09-25
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Largest Biotech Event of Thailand Takes Center Stage
2023-09-22
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top